Navigation Links
New tumor-suppressor gene discovered

hniques, we were able to introduce a normal mats gene into the chromosomes of flies whose mats gene was mutated," Lai explains. "We found that the line of flies with this additional normal mats gene no longer developed tumors.

The researchers also inserted a human mats gene into the line of mats-mutant flies and found that the human gene is able to perform the same function as the fly gene. Additional experiments also revealed that the mats gene is required for normal differentiation of eye cells during the development of the fly's eye.

Lai's team also tackled the tough challenge of discovering how the mats gene is able to suppress the growth of tumors. "We did not find many clues when we compared the sequence of the mats gene with the sequence of other genes in the public databases," Lai says. "But we did find a counterpart to the mats gene in yeast. This yeast counterpart is known to make a protein that forms a complex with a kinase--an enzyme that catalyzes genetic activity--so we wondered if the protein product of our mats gene also could function in this way." Lai was particularly intrigued by the possibility that the protein product of the mats gene could partner with the kinase product of a known tumor-suppressor gene named "wts," which turned out to be the case.

The researchers performed three experiments to test whether the mats and wts genes interact genetically. In the first experiment, they inserted an additional normal mats gene into a line of flies and found no change in the shape of the flys' eyes. In the second experiment, they inserted an additional normal wts gene and found that the fly's eyes were decreased in size and deformed. In the third experiment, they inserted both a mats gene and a wts gene. "We found that mats and wts together can shrink the fly's eye much more dramatically," Lai reports. "Their effect is not additive, but synergistic. The two genes have a more powerful effect when they combine to work together in
'"/>

Source:Penn State


Page: 1 2 3 4

Related biology news :

1. Function of new cancer genes discovered
2. Novel mechanism for DNA replication discovered
3. Mechanism for Epstein-Barr virus proteins role in blood cancers discovered
4. Small molecule inhibitor of cholera discovered
5. Source of crucial immune cell in the skin discovered
6. Parkinsons disease mechanism discovered
7. Stomach receptor for H. pylori discovered
8. Emotional control circuit of brains fear response discovered
9. New dopamine brain target discovered
10. New hereditary breast cancer gene discovered
11. New mechanism for nutrient uptake discovered
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New tumor suppressor gene discovered

(Date:8/5/2015)... , August 5, 2015 ... titled "Facial Recognition Market - Global Industry Analysis, Size, ... global market for facial recognition is forecast to reach ... by increased demand for surveillance systems by civil and ... number of crimes and terrorist activities across the globe ...
(Date:8/3/2015)... 2015 Synaptics, Inc. (Nasdaq: SYNA ), ... that members of the executive management team will present ... Technology Leadership Forum on Tuesday, August 11, 2015 at ... at the Sonnenalp Resort in Vail, CO. ... forward-looking information. An audio webcast of the event will ...
(Date:7/31/2015)... La 10e Conférence internationale sur la ... le BGI du 22 au 25 octobre 2015 ... La conférence célèbre son 10e anniversaire ... est devenue l,une des réunions annuelles mondiales les ... c,est aussi la plus dynamique, la plus enthousiaste ...
Breaking Biology News(10 mins):Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 2Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 3Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 4Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 5Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 6La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 2La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 3
... a grant of $8,950,590 provided through the American Recovery and ... Diego looking for the biological bases of differences in human ... collect a wealth of data about brain development in children. ... Institute on Drug Abuse (NIDA), a part of the National ...
... authorized more than $29 million for the University of ... a former gold mine in South Dakota into the ... by the National Science Board, is for a preliminary ... (DUSEL), a facility at the former Homestake gold mine ...
... including a University of Florida paleontologist has used a ... provide the first reliable evidence of how Neotropical rainforests ... Smithsonian Institution and UF, among others, found that many ... rainforests including legumes, palms, avocado and banana ...
Cached Biology News:Stimulus grant of nearly $9 million to UC San Diego funds big study of young brains 2Stimulus grant of nearly $9 million to UC San Diego funds big study of young brains 3NSF authorizes $29 million for preliminary design of world's deepest underground laboratory 2NSF authorizes $29 million for preliminary design of world's deepest underground laboratory 3Plant fossils give first real picture of earliest Neotropical rainforests 2Plant fossils give first real picture of earliest Neotropical rainforests 3
(Date:8/31/2015)... MARLBOROUGH, Mass. , Aug. 31, 2015 /PRNewswire/ ... biotechnology company focused on discovering and developing innovative ... ophthalmology, today announced that the 30-day review period ... Drug (IND) for ocular indications with the U.S. ... the IND is now active. ...
(Date:8/31/2015)... HAYWARD, Calif. and SHANGHAI ... Inc., a privately-held biopharmaceutical company developing next-generation antibiotics, ... Phase 2 clinical study for its lead drug ... designed to treat drug-resistant bacteria such as MRSA ... safer and better tolerated therapeutic option than currently ...
(Date:8/31/2015)... 31, 2015 LabStyle Innovations Corp. (OTCQB: ... today announced it recently closed a round of ... used to support the global rollout and initial ... cloud-based, diabetes management solution that includes novel software ... glucose monitoring device, and for working capital purposes. ...
(Date:8/31/2015)... Grove, IL (PRWEB) , ... August 31, 2015 ... ... impurities (PGIs), as a high priority in the drug development approval process. Thus, ... , This year, Regis Technologies, Inc., a Chicago-based CMO, has been hosting ...
Breaking Biology Technology:RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109 2RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109 3RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109 4MicuRX Reports Positive Top-Line Results In Phase 2 Clinical Trial For Novel Antibiotic MRX-I In Complicated Skin And Soft Tissue Infections 2LabStyle Innovations Closes $2.5 Million Funding to Support Global Rollout of Dario Diabetes Management Solution 2LabStyle Innovations Closes $2.5 Million Funding to Support Global Rollout of Dario Diabetes Management Solution 3LabStyle Innovations Closes $2.5 Million Funding to Support Global Rollout of Dario Diabetes Management Solution 4Regis Shares Expert Advice on Impurities in Drug Development 2Regis Shares Expert Advice on Impurities in Drug Development 3
... Thailand, Sept. 8 Don Margolis, Chairman of,The ... ) based in,Bangkok, Thailand told The Wall Street ... that future profits inside the stem cell,research sector ... next five years, even for,companies specializing in Repair ...
... PRINCETON, New Jersey and SAN DIEGO,California, September 8 , ... for Continuous Process,Chemistry Technologies and for Further Global Expansion, ... investment of $3.3M,by a group of private and financial ... Graphisoft and Dave Tapolczay, CEO of Medical,Research Council Technology ...
... Sept. 8 /PRNewswire-FirstCall/,-- Concuity, a healthcare division ... a leading,provider of contract management and revenue ... today announced that Valley Baptist Health,System has ... more,accurately calculate payments from managed care and ...
Cached Biology Technology:Stem Cell Profits Five Years Away, Says Repair Stem Cell Institute Chairman to The Wall Street Transcript 2World Leader in Bench-Top Flow Chemistry Instruments ThalesNano, Inc. Closes Funding Round 2Valley Baptist Health System Selects Concuity's ClearContracts to More Accurately Calculate Payments from Managed Care and Government Payers 2Valley Baptist Health System Selects Concuity's ClearContracts to More Accurately Calculate Payments from Managed Care and Government Payers 3Valley Baptist Health System Selects Concuity's ClearContracts to More Accurately Calculate Payments from Managed Care and Government Payers 4
... Timp-4 has been reported in heart ... fibroblasts in cell culture conditions. ... TPA stimulates production of TIMP-4 in ... protein levels produced often require concentration ...
Goat polyclonal to HSPC150 ( Abpromise for all tested applications). entrezGeneID: 29089...
Anti-MMP-13 Collagenase-3, amino terminal end of active enzyme; rabbit host...
...
Biology Products: